Julie Rosenberg, MD

Julie Rosenberg, MD, is an experienced life sciences leader with a proven track record of success in leading global drug development and pharmacovigilance programs. As a highly skilled pediatric hematologist-oncologist and accomplished business leader, she thrives when solving complex challenges in clinical development, trial design, operational efficiency and regulatory strategy.

As Chief Medical Officer, Dr. Rosenberg provides high-level leadership, strategic oversight and direct support for clinical development programs. She leverages her deep insights to guide the internal team and to facilitate external company interactions with thought leaders, investors and global regulatory authorities. She demonstrates a keen ability to balance high-level strategic vision with tactical execution.

Dr. Rosenberg graduated from the University of Missouri-Kansas City School of Medicine and completed her Pediatrics residency and Pediatric Hematology-Oncology fellowship at Baylor College of Medicine. She has held leadership roles at the University of Texas Southwestern Medical School and at four major pharmaceutical companies: Boehringer Ingelheim, Bristol Myers Squibb, Bayer Healthcare and Pfizer. Over the past five years, Dr. Rosenberg served as a senior consultant and advisor for nearly 40 biotech companies and one contract research organization.

Recognized for her leadership skills and impact, Dr. Rosenberg is an invited member of both the Marshall Goldsmith ‘MG’ 100—a premier network of top business leaders, coaches and consultants— and the International Women’s Forum, a global organization of influential female leaders dedicated to driving progress and change.